Could Drug Price Spikes Spur ANDA Priority Reviews?
This article was originally published in The Pink Sheet Daily
Executive Summary
Sens. Collins and Warren want FDA to have economic trigger to speed generics; CDER's Woodcock says it's possible but needs clear legislative definition.
You may also be interested in...
Gottlieb Places Drug Pricing Out Front In First Speech To US FDA Staff
New FDA Commissioner tells employees that 'too many consumers are priced out of medicines they need' and that FDA must take meaningful steps to get lower cost alternatives to market.
Gottlieb Places Drug Pricing Out Front In First Speech To US FDA Staff
New FDA Commissioner tells employees that 'too many consumers are priced out of medicines they need' and that FDA must take meaningful steps to get lower cost alternatives to market.
FDA's Next Commissioner: Will Trump Follow Hamburg Or McClellan 'Schedule'?
Nothing seems conventional about this presidency, but history suggests a nomination may not arrive for another month or longer, and thereafter confirmation could be swift.